title: What are the biological and therapeutic implications of biomolecule corona formation on the surface of inhaled nanomedicines?
authors.affiliation: Institute of Pharmaceutical Science, King's College London, London, UK.
authors.forename: Abhinav
authors.initials: A
authors.lastname: Kumar
authors.forename: Ben
authors.initials: B
authors.lastname: Forbes
authors.forename: Ian
authors.initials: I
authors.lastname: Mudway
authors.forename: Elif Melis
authors.initials: EM
authors.lastname: Bicer
authors.forename: Lea Ann
authors.initials: LA
authors.lastname: Dailey
mesh_terms: D000280:Administration, Inhalation; D016503:Drug Delivery Systems / Q000379:methods; D006801:Humans; D050997:Nanomedicine / Q000379:methods; D011663:Pulmonary Surfactants / Q000378:metabolism; D012137:Respiratory System / Q000378:metabolism
chemical_list: D011663:Pulmonary Surfactants
keywords: Keywords:; alveolar macrophages; complement; inhaled nanomedicines; protein corona; pulmonary drug delivery; respiratory tract lining fluid; surfactant proteins